国际肿瘤学杂志

国际肿瘤学杂志 ›› 2014, Vol. 41 ›› Issue (11): 848-851.doi: 10.3760/cma.j.issn.1673-422X.2014.11.015

• 综述 • 上一篇    下一篇

洛铂在妇科肿瘤治疗中的研究新进展

  

  1. 复旦大学肿瘤医院妇科(杨志敏、王华英)，放疗科(林原、陈佳艺)
  • 出版日期:2014-12-03 发布日期:2015-01-20
  • 通讯作者: 林原， Email：214667959@qq.com

New progression of lobaplatin in the treatment of gynecologic cancer

  1. Department of Radiation Oncology, Cancer Hospital Fudan University, Shanghai 200032, China
  • Online:2014-12-03 Published:2015-01-20
  • Contact: Lin Yuan, Email: 214667959@qq.com

PDF

1445

摘要： 洛铂是第3代铂类抗肿瘤药物，已上市用于临床治疗晚期乳腺癌、小细胞肺癌和慢性粒细胞白血病。研究表明洛铂作为最新的第3代铂类抗肿瘤药物，具有水溶性好，抗瘤谱广、抗瘤活性强，与其他铂类药物无交叉耐药性及不良反应低诸多特点，已经显示出明显的优势。

关键词: 洛铂； 生殖器肿瘤, 女（雌）性； 药物疗法

Abstract: Lobaplatin is the third generation platinum anticancer drug, and has been listed for the clinical treatment of advanced breast cancer, small cell lung cancer and chronic myeloid leukemia. Studies have shown that lobaplatin as the latest third generation platinum anticancer drug, has good water solubility, broadspectrum antitumor, strong antitumor activity, no crossresistance with other platinum drugs, low toxicity and many other features. Lobaplatin  has shown a clear advantage.

Key words: Lobaplatin, Genital neoplasms, female, Drug therapy